Focus Pharma SA
The score of Focus Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +113 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Focus Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Focus Pharma's financial analysis
- Solvency-1197.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Focus Pharma
Focus Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.744.870
- VAT number
- BE0846744870
- Peppol
- Registered · 0208:0846744870 · as of 09 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Jun 2012
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Focus Pharma (SA) has been based in Leuven since 2012, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 20,562 € and equity of −91,912 €; its revenue is not published. Its solvency stands at -1197.8%, below the median of its sector (46.0%).
Companies similar to Focus Pharma
Companies in the same business, of comparable size and area, outside its group.
- Orbi-Pharma International Wholesale of pharmaceutical and medical goods Bierbeek · balance sheet 161,674 €
- Taikun Pharmaceutical Technology Manufacture of basic pharmaceutical products Ghent · balance sheet 275,396 €
- Confort AT Home Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet 7,413 €
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- RevaTis Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €4.12m
- Healthcare2Business Wholesale of pharmaceutical and medical goods Brasschaat · balance sheet 4,018 €
- LD Medical Devices Wholesale of pharmaceutical and medical goods Wavre · balance sheet 19,257 €
Frequently asked questions about Focus Pharma
What is the revenue of Focus Pharma?
Focus Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Focus Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0846744870 for Focus Pharma, if the company is VAT-registered. Its company number (CBE) is 0846.744.870.
Where is the registered office of Focus Pharma?
According to the CBE register, the registered office of Focus Pharma is in 3001 Leuven.
What is the equity of Focus Pharma?
At the close of the 2025 financial year, the equity of Focus Pharma amounts to -91,912 €, a solvency of -1197.8% of total assets.
Who manages Focus Pharma?
The register lists 3 active mandates at Focus Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Focus Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →